Praxis Launches International Patient Recruitment Campaign for Neurogenic Overactive Bladder Study.

BRENTWOOD, Tenn. -- Praxis, a company specializing in centralized patient recruitment for clinical research studies, is providing marketing communications services to a major pharmaceutical firm for a clinical trial for patients with urinary incontinence. The study will determine the safety and effectiveness of an investigational medication in managing the symptoms of urinary incontinence caused by neurogenic detrusor overactivity in both men and women who have MS or a spinal cord injury (SCI) and have not been adequately managed with anticholinergic therapy.

The study will take place in the US and five other countries worldwide. Praxis is providing a variety of recruitment services including patient education materials and retention items, community outreach/awareness programs, advocacy group partnerships and an informational website. Materials will be developed for six different countries, and incorporate ten different languages to reach the specific target audiences on a global basis.

Praxis' President David Fox adds, "This multi-national program allows us to create customized recruitment materials that are tailored to each country. We look forward to executing a successful recruitment campaign that will help our sponsor exceed current enrollment goals and deliver qualified patients to sites worldwide. In addition, this study may provide another treatment option for patients that have not been managed successfully with the current therapies available."

Praxis Communications, Inc., headquartered in Brentwood, Tenn., provides the pharmaceutical and biotech industries with a wide range of services for patient recruitment and retention for clinical trials including patient profiling, recruitment planning, centralized fulfillment, media relations, advertising, and program management. For more information call Praxis at [phone] or visit www.GoPraxis.com.